Navigation Links
Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
Date:2/14/2011

NEW YORK and LONDON, Feb. 15, 2011 /PRNewswire/ -- Pharmaceutical companies are dramatically increasing their investments in new and innovative offerings to meet the demands of a patient-empowered, data-driven, outcomes-focused future in health care. In the last year alone, pharmaceutical company investment in smart phone apps, educational websites, social media platforms, wireless devices and other programs increased 78%, as companies embrace a role that goes far beyond developing and manufacturing products.

While many of these initiatives involve collaborating in new ways with non-pharmaceutical companies, investments by these same non-pharma companies are outpacing those made by pharma companies, challenging industry members to either increase their level of investment or risk diminished relevance. These findings and other insights were released today in Progressions: Building Pharma 3.0, Ernst & Young's annual global pharmaceutical report.

The Progressions report provides a detailed update on the transformation currently underway in the pharmaceutical industry — one in which companies will need to shift from simply producing new medicines to demonstrating improvements in health outcomes and creating innovative new business models, an ecosystem that EY has entitled "Pharma 3.0." This evolution is being driven both by rapid advancements in health care technology and the coming to a head of health care's lack of sustainability globally.

The opportunities latent in these shifts are attracting a growing flood of non-traditional players to the health care space. The report estimates that non-pharma players have publicly committed at least US$20 billion in experiments with Pharma 3.0 related business models, an investment level several multiples larger than the allocations made by the pharmaceutical industry.

"New entrants to the health care industry are clearly committing much more to business model innovation th
'/>"/>

SOURCE Ernst & Young
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock
2. Managed Health Care Associates, Inc. (MHA) Announces Expansion of Specialty Pharmaceutical Program
3. Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing
4. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
5. AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering
6. Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing
7. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
8. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
9. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
10. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
11. Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
(Date:1/15/2014)... 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ... System as a non-invasive, wireless continuous glucose monitoring system, ... Chairman and Interim CEO of Echo Therapeutics, will present ... Conference. Mr. Doman will make a ...
(Date:1/15/2014)... to Millennium Research Group (MRG), the global authority ... United States and European transcatheter embolization ... through 2022, with embolization particles representing one of ... drug-eluting beads (DEBs) and radioembolization spheres in interventional ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Improved Long-term [Five-years],Overall Survival for these Seriously ... -- FOLFOX4, an,Eloxatin(R)-based chemotherapy regimen, provided significant,improvements ... and,time to disease progression (TTP) - a ... with metastatic (advanced) colorectal cancer.,Importantly, the FOLFOX4 ...
... Presented at Society of Nuclear,Medicine Annual Meeting ... Inc. , a biopharmaceutical company focused on,developing ... serious,diseases, today announced that its anti-carcinoembryonic antigen,(CEA) ... found to be safe and active when ...
Cached Medicine Technology:Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New,Treatment Benchmark in Patients With Metastatic Colorectal Cancer 2Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New,Treatment Benchmark in Patients With Metastatic Colorectal Cancer 3Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New,Treatment Benchmark in Patients With Metastatic Colorectal Cancer 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 2Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 3Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 5
(Date:7/9/2014)... the Perelman School of Medicine at the University of ... have received an $8 million grant from the National ... light therapy (PDT) in patients with malignant pleural mesothelioma, ... manifests itself in the lining of the lungs and ... grant will fund a clinical trial and additional studies ...
(Date:7/9/2014)... active in almost all types of cancer sends the ... help fuel a tumour,s uncontrolled growth, new research suggests. ... identified a molecular trigger responsible for ratcheting up activity ... that makes the building blocks cancer cells need to ... pathway, called SREBP, controls the flow of messages to ...
(Date:7/9/2014)... cancer, researchers have uncovered mutations in a cell-signaling pathway ... knowledge may expand treatments for patients because drugs targeting ... are in clinical trials. , Reporting July 9 in ... (TCGA), including researchers at Washington University School of Medicine ... studied tumors from 230 patients with lung adenocarcinoma. , ...
(Date:7/9/2014)... Center paint a relatively optimistic picture of women,s chances ... spread to the chest wall or skin, but not ... regardless of size and whether they have involved lymph ... called "locally advanced" tumors, suggesting that they are a ... Locally advanced breast cancers of this and other types ...
(Date:7/9/2014)... used in policing injection drug users in Russia ... , A study, conducted by researchers from ... in collaboration with St. Petersburg Pavlov State University, ... on the health outcomes of a cohort of ... , Those who were arrested by police were ...
Breaking Medicine News(10 mins):Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Lung cancer study hints at new treatments 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:BU researchers relate arrests with HIV risk environment 2
... ... for the treatment of acute injuries and chronic conditions affecting soft tissues, such as ... ... Therapy, a leading provider of physical medicine and rehabilitation services in the metropolitan New ...
... Arizona criminal attorney ... case of State v. Norton. The Downtown Justice Court suppressed Norton,s breath alcohol readings of ... Phoenix, ... was able to get the breath alcohol readings suppressed in the case of State V. ...
... Moderate Traumatic Brain Injury (TBI) today released the following statement regarding Brain Injury Awareness Month: , ... , , ... ... "BHR Pharma ...
... March 23 Healthcare organizations looking to reduce costs and improve patient care by extending their information management to the mobile world can now do so without undergoing ... ... ... ...
... secure and trusted environment using MobiSecure® SMS, a new product introduced today by Diversinet Corp. (OTC Bulletin Board: DVNTF; TSX Venture: DIV). , ... , ... ... ...
... be harder to lie about your age or your poker ... has revealed that our eye position betrays the numbers we ... asked to state a series of random numbers. By measuring ... predict with reliable confidence the next chosen number - before ...
Cached Medicine News:Health News:New York Sports Medicine Offers Platelet Rich Plasma Therapy For Treatment of Injury 2Health News:New York Sports Medicine Offers Platelet Rich Plasma Therapy For Treatment of Injury 3Health News:Arizona Criminal Attorney Gets Breath Alcohol Readings Suppressed 2Health News:BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now 2Health News:BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now 3Health News:Diversinet Extends Reach of Mobile Healthcare Information With New Product Release Targeting Healthcare Organizations 2Health News:Diversinet Extends Reach of Mobile Healthcare Information With New Product Release Targeting Healthcare Organizations 3Health News:Diversinet Extends Reach of Mobile Healthcare Information With New Product Release Targeting Healthcare Organizations 4Health News:Diversinet Extends Reach of Mobile Healthcare Information With New Product Release Targeting Healthcare Organizations 5Health News:Diversinet Extends Reach of Mobile Healthcare Information With New Product Release Targeting Healthcare Organizations 6Health News:Diversinet Extends Reach of Mobile Healthcare Information With New Product Release Targeting Healthcare Organizations 7Health News:Diversinet's New MobiSecure(R) SMS Provides Healthcare Organizations With Secure and Protected SMS Communications 2Health News:Diversinet's New MobiSecure(R) SMS Provides Healthcare Organizations With Secure and Protected SMS Communications 3Health News:Diversinet's New MobiSecure(R) SMS Provides Healthcare Organizations With Secure and Protected SMS Communications 4Health News:Diversinet's New MobiSecure(R) SMS Provides Healthcare Organizations With Secure and Protected SMS Communications 5Health News:Diversinet's New MobiSecure(R) SMS Provides Healthcare Organizations With Secure and Protected SMS Communications 6Health News:Our eye position betrays the numbers we have in mind, new study 2
This legless table has adjustable height and round post. Pad sold separately....
This table has adjustable height, an integral leg, and blade post. Includes a standard 2" (5 cm) pad....
This table has adjustable height, round post, and universal clamp. Replacement 1" (5 cm) or 2" (2.5 cm) pad sold separately....
... An excellent choice for orthopedic procedures. ... width to 24" for the ... clamps quickly attach to any O.R. ... easy C-Arm access and stability. ...
Medicine Products: